₹ 2,209.00
-7.20 (-0.32%)
E
Emcure Pharmaceuticals
₹ 2,209.00
Emcure Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Emcure Pharmaceuticals as of Q2 Sep 2026 stands at ₹17.16. This is a 10.71% growth quarter on quarter and 33.54% growth same quarter last year. For the FY2026 the EPS of Emcure Pharmaceuticals stands at ₹48.77. This is a 33.87% growth compared with FY2025.
Emcure Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

